DocGo to report narrower Q2 loss after raising FY2026 sales guidance
DocGo Inc. will release its second-quarter earnings after Monday’s close, with analysts expecting a 15-cent loss per share on $75.57 million of revenue versus a 21-cent loss and $80.42 million a year ago.
DocGo Inc. (NASDAQ: DCGO ) will release its second earnings report after the closing bell on Monday, Aug.
17.
Analysts expect the New York-based company to report a quarterly loss of 15 cents per share, versus a loss of 21 cents per share in the year-ago period.
The consensus estimate for DocGo’s quarterly revenue is $75.57 million.
It reported $80.42 million last year, according to Pro.
On May 11, DocGo raised its FY2026 sales guidance.
DocGo shares fell 2.5% to close at $0.65 on Thursday. readers can access the latest analyst ratings on the Analyst Stock Ratings page.
Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let’s have a look at how most-accurate analysts have rated the company in the recent period.
Canaccord Genuity analyst Richard Close maintained a Hold rating and cut the price target from $1.5 to $1 on March 25, 2026.
This analyst has an accuracy rate of 53%.
Stifel analyst David Grossman maintained a Buy rating and lowered the price target from $4 to $2.5 on March 17, 2026.
This analyst has an accuracy rate of 60%.
Needham analyst Ryan MacDonald maintained a Buy rating with a price target of $3 on March 17, 2026.
This analyst has an accuracy rate of 57%.
Considering buying DCGO stock? Here’s what analysts think: Photo via Shutterstock